Over the last 7 days, the United States market has dropped 2.7%, yet it has shown resilience with a 23% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, growth companies with high insider ownership, such as ATRenew and two others we'll explore, can be particularly appealing as they often indicate strong internal confidence in their long-term potential.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	74.1%
Upstart Holdings (UPST)	14.1%	58.1%
SharonAI Holdings (SHAZ)	32.5%	105.4%
QT Imaging Holdings (QTI)	23.9%	104.2%
Karman Holdings (KRMN)	15.6%	52.6%
FirstSun Capital Bancorp (FSUN)	21%	54.2%
Figure Technology Solutions (FIGR)	26.8%	54.1%
Corcept Therapeutics (CORT)	11.7%	48.9%
Astera Labs (ALAB)	10.3%	29.3%
AppLovin (APP)	27.5%	21.7%

We'll examine a selection from our screener results.

ATRenew (RERE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: ATRenew Inc. operates in the People's Republic of China, focusing on selling pre-owned consumer electronics through online platforms and other channels, with a market cap of approximately $897.30 million.

Operations: The company's revenue primarily comes from its retail segment, specifically in electronics, generating CN¥22.55 billion.

Insider Ownership: 11.9%

Earnings Growth Forecast: 32% p.a.

ATRenew has shown strong earnings growth, with a 236.3% increase over the past year, and forecasts suggest continued significant annual profit growth of 32%, outpacing the US market. The company trades at a favorable P/E ratio of 14.4x compared to the US market's 18.7x, indicating good relative value. Recent earnings guidance projects revenue increases between 25% and 27% year-over-year for Q2 2026, highlighting ongoing expansion potential amidst substantial insider ownership dynamics.

Ryan Specialty Holdings (RYAN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Ryan Specialty Holdings, Inc. is a service provider offering specialty products and solutions to insurance brokers, agents, and carriers across various regions including the United States, Canada, Europe, India, Singapore and more; it has a market cap of $8.58 billion.

Operations: The company generates revenue primarily from its Insurance Brokers segment, which accounts for $3.10 billion.

Insider Ownership: 12.1%

Earnings Growth Forecast: 63.5% p.a.

Ryan Specialty Holdings has demonstrated strong earnings growth, with a 113% increase over the past year, and forecasts indicate a significant annual profit growth of 63.5%, surpassing the US market average. Insider activity shows more shares have been bought than sold recently, indicating confidence in future prospects. The company expanded its buyback program by $300 million to $600 million, reflecting robust financial positioning despite slower revenue growth projections compared to the broader market.

Warby Parker (WRBY)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Warby Parker Inc. operates as a retailer of eyewear products through both physical stores and an e-commerce platform in the United States and Canada, with a market cap of approximately $2.79 billion.

Operations: The company's revenue primarily comes from its Holistic Vision Care segment, which generated $890.57 million.

Insider Ownership: 14.8%

Earnings Growth Forecast: 71.4% p.a.

Warby Parker has seen significant insider selling recently, though its earnings are forecast to grow substantially at 71.4% annually, outpacing the US market. The company's revenue is projected to grow by 17.7% per year, faster than the broader market but below 20%. Recent product innovations like Intelligent Eyewear and Warby Parker Sport highlight its strategic expansion into new categories, aligning with consumer demand for multifunctional eyewear solutions.

Taking Advantage

• Click here to access our complete index of 175 Fast Growing US Companies With High Insider Ownership.
• Want To Explore Some Alternatives? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.